NASDAQ: SNOA | Healthcare / Drug Manufacturers - Other / USA |
0.8200 | +0.0600 | +7.89%![]() | Vol 174 941 | 1Y Perf -80.89% |
Feb 21st, 2019 15:57 |
BID | 0.8000 | ASK | 0.8200 | ||
Open | 0.8000 | Previous Close | 0.7600 | ||
Pre-Market | - | After-Trading | - | ||
- -% | - -% |
Target Price | 5.00 | Analyst Rating | Moderate Buy 1.67 | |
Potencial % | 509.76 | Finscreener Ranking | ★★★+ ![]() | |
Insiders Trans % 3/6/12M | -/-/100 | Value Ranking | ★★★ ![]() | |
Insiders Value % 3/6/12M | -/-/100 | Growth Ranking | ★★ ![]() | |
Insiders Shares Cnt. % 3/6/12M | -/-/100 | Income Ranking | — - | |
Market Cap (mil) | 5 | Earnings Rating | Neutral | |
Price Range Ratio 52wk % | 4.33 | Earnings Date | 20th Feb 2019 |
Today's Price Range 0.80000.8200 | 52wk Range 0.64004.80 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Month | 7.89% | ||
3 Months | -7.87% | ||
6 Months | -58.38% | ||
1 Year | -80.89% | ||
3 Years | -83.43% | ||
5 Years | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Quick Ratio | 2.30 | |||
Current Ratio | 3.80 | |||
Long Term Debt to Total Capital | 0.01 | |||
Total Debt to Equity | 0.03 | |||
Interest Coverage | -363.80 | |||
Leverage Ratio | 1.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Gross Margin | 44.10 | |||
EBIT Margin | -79.70 | |||
EBITDA Margin | -77.00 | |||
Pre-tax Profit Margin | -75.20 | |||
Profit Margin | -84.72 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
PE Ratio | - | |||
PB Ratio | 0.77 | |||
PS Ratios | 0.62 | |||
Price to Cash Flow | 10.50 | |||
Price to Free Cash Flow | -0.80 | |||
Cash Flow Per Share | -2.13 | |||
Price to Tangible Book | 0.77 | |||
Book Value per Share | 0.97 | |||
Enterprise Value (in ths.) | 4 526 |
Management Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Return on Equity (5Y Avg) | -29.52 | |||
ROE last 12 Months | -106.26 | |||
Return on Assets (5Y Avg) | -22.74 | |||
ROA last 12 Months | -82.97 | |||
Return on Capital (5Y Avg) | -24.99 | |||
ROC last 12 Months | -104.50 | |||
Return on invested Capital Q | -23.63 | |||
Return on invested Capital Y | -77.13 | |||
Assets Turnover | 0.60 | |||
Receivables Turnover | 4.70 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Revenue LTM (in ths.) | 12 963 | |||
Revenue per Share | 1.16 | |||
Revenue Growth 3 Years | -1.35 | |||
Revenue Growth 5 Years | 1.97 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Dividend Yield | - | |||
Dividend Rate | - | |||
Dividend Growth 3 Years | - | |||
Dividend Growth 5 Years | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2019 | -0.21 | -0.26 | -23.81 |
Q02 2019 | - | -0.44 | - |
Q01 2019 | - | -0.55 | - |
Q04 2018 | -0.65 | -0.93 | -43.08 |
Q03 2018 | -0.63 | -0.73 | -15.87 |
Q02 2018 | -0.75 | -0.67 | 10.67 |
Q01 2017 | - | -0.61 | - |
Q04 2016 | - | -0.16 | - |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2019 QR | -0.20 | 90.00 | Positive |
3/2019 QR | -0.20 | - | - |
3/2019 FY | -1.21 | - | - |
3/2019 FY | -2.20 | 0.00 | - |
Next Report Date | - |
Estimated EPS Next Report | -0.21 |
Estimates Count | 1 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 174 941 |
Shares Outstanding (in ths.) | 6 593 |
Trades Count | 219 |
Dollar Volume | 140 177 |
Avg. Volume | 90 551 |
Avg. Weekly Volume | 209 655 |
Avg. Monthly Volume | 84 339 |
Avg. Quarterly Volume | 106 715 |
Week | Month | Three Months | Six Months |
---|---|---|---|
Bearish Bullish 50%50% | Bearish Bullish 58%42% | Bearish Bullish 65%35% | Bearish Bullish 70%30% |
There are no comments yet.
![]() | ![]() | ![]() | ![]() | ![]() | ![]() |